Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q3 2022 · 10-Q
Revenue$13.04M$13.04M+124.0% vs Q3 2021 Net Income-$1.47M-$1.47MN/M vs Q3 2021 EPS Diluted-$0.18-$0.18N/M vs Q3 2021 Gross Profit$10,816,010+103.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,643,059N/M Free Cash Flowderived-$1,655,818N/M Margins · derivedGross margin82.9%−8.2 pt vs Q3 2021
Operating margin-24.8%+7.1 pt vs Q3 2021
Net margin-11.3%+23.9 pt vs Q3 2021
ended Sep 30, 2022 · filed Nov 14, 2022 · 45 d after period end